首页 | 本学科首页   官方微博 | 高级检索  
     

阿德福韦酯联合拉米夫定与恩替卡韦单药治疗乙肝肝硬化的效果
引用本文:王天光. 阿德福韦酯联合拉米夫定与恩替卡韦单药治疗乙肝肝硬化的效果[J]. 中国实用医药, 2021, 0(9): 13-15
作者姓名:王天光
作者单位:辽宁省沈阳市沈北新区中心医院感染性疾病科
摘    要:目的 分析阿德福韦酯联合拉米夫定与恩替卡韦单药治疗乙型病毒性肝炎(乙肝)肝硬化的效果.方法 68例乙肝肝硬化患者,依据随机数字表法分为对照组及观察组,每组34例.对照组口服阿德福韦酯联合拉米夫定治疗,观察组服用恩替卡韦治疗.12周后复查,比较两组患者的治疗效果、不良反应发生情况及治疗前后的肝功能指标[凝血酶原活动度(P...

关 键 词:恩替卡韦  阿德福韦酯  拉米夫定  乙肝肝硬化  疗效

Effect of adefovir dipivoxil combined with lamivudine and entecavir monotherapyin the treatment of hepatitis B cirrhosis
WANG Tian-guang. Effect of adefovir dipivoxil combined with lamivudine and entecavir monotherapyin the treatment of hepatitis B cirrhosis[J]. China Practical Medical, 2021, 0(9): 13-15
Authors:WANG Tian-guang
Affiliation:(Department of Infectious Diseases,Shenbei New District Central Hospital,Shenyang 110121,China)
Abstract:Objective To analyze the effect of adefovir dipivoxil combined with lamivudine and entecavir monotherapy in the treatment of hepatitis B cirrhosis.Methods A total of 68 patients with hepatitis B cirrhosis were divided into control group and observation group according to random numerical table,with 34 cases in each group.The control group was treated with oral administration of adefovir dipivoxil combined with lamivudine,and the observation group was treated with oral administration of entecavir.The therapeutic effects,occurrence of adverse reactions,and liver function indicators[prothrombin activity(PTA),aspartate aminotransferase(AST),total bilirubin(TBIL),alanine aminotransferase(ALT)]and liver fibrosis indicators[typeⅣcollagen(CⅣ),laminin(LN),typeⅢprocollagen amino peptide(PⅢNP),hyaluronic acid(HA)]before and after treatment were compared between the two groups.Results After treatment,the levels of PTA,AST,TBIL,ALT,CⅣ,LN,PⅢNP and HA of the two groups were improved compared with those before treatment,and the improvement of the observation group was better than that of the control group.All the difference was statistically significant(P<0.05).The total effective rate 91.18%of the observation group was higher than 70.59%of the control group,and the difference was statistically significant(P<0.05).The incidence of adverse reactions of the observation group was 2.94%(1/34),which was lower than 20.59%(7/34)of the control group,and the difference was statistically significant(P<0.05).Conclusion There are differences in the effect of adefovir dipivoxil combined with lamivudine and entecavir monotherapy in the treatment of hepatitis B cirrhosis.Entecavir monotherapy has better effect and safety,which can relieve the clinical symptoms of patients,promote the improvement of liver function and liver fibrosis,and is worthy of promotion and application.
Keywords:Entecavir  Adefovir dipivoxil  Lamivudine  Hepatitis B cirrhosis  Efficacy
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号